A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Macular Edema
Interventions
DRUG

Ranibizumab

Liquid ranibizumab (10 mg/ml) was supplied in a sterile solution in single-use vials.

Trial Locations (42)

14620

Rochester

15212

Pittsburgh

15213

Pittsburgh

17011

Camp Hill

19107

Philadelphia

21287

Baltimore

21740

Hagerstown

28210

Charlotte

29169

West Columbia

29456

Ladson

30909

Augusta

32701

Altamonte Springs

33426

Boynton Beach

33805

Lakeland

37203

Nashville

49201

Jackson

55435

Edina

57701

Rapid City

60637

Chicago

77030

Houston

77384

The Woodlands

78240

San Antonio

78705

Austin

79606

Abilene

80401

Golden

80909

Colorado Springs

85020

Phoenix

85704

Tucson

89144

Las Vegas

90211

Beverly Hills

90503

Torrance

92705

Santa Ana

93103

Santa Barbara

94040

Mountain View

94107

San Francisco

94609

Oakland

95973

Chico

06320

New London

02114

Boston

01605

Worcester

08225

Northfield

07666

Teaneck

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY